Suppr超能文献

在离体牛外侧隐静脉生物测定中麦角新碱诱导的血管收缩。

Ergovaline-induced vasoconstriction in an isolated bovine lateral saphenous vein bioassay.

作者信息

Klotz J L, Bush L P, Smith D L, Shafer W D, Smith L L, Arrington B C, Strickland J R

机构信息

Forage-Animal Production Research Unit, USDA-ARS, Lexington, KY 40546, USA.

出版信息

J Anim Sci. 2007 Sep;85(9):2330-6. doi: 10.2527/jas.2006-803. Epub 2007 May 15.

Abstract

Ergovaline has been proposed as a toxic component of endophyte-infected tall fescue. As many of the symptoms of fescue toxicosis are a result of compromised circulation, the objective of this study was to examine the vasoconstrictive potentials of ergovaline and a more documented ergopeptine, ergotamine, using a bovine, lateral (cranial branch) saphenous vein bioassay. Segments of the cranial branch of the lateral saphenous vein (2 to 3 cm) were collected from healthy, mixed breed cattle (n = 12 and n = 5 for the ergovaline and ergotamine experiments, respectively) at local abattoirs. The veins were trimmed of excess fat and connective tissue, sliced into 2- to 3-mm cross sections, and suspended in a myograph chamber containing 5 mL of a modified Krebs-Henseleit, oxygenated buffer (95% O2 + 5% CO2; pH = 7.4; 37 degrees C). The tissue was allowed to equilibrate at 1 g of tension for 90 min before of the addition of treatments. Increasing doses of ergovaline (1x10(-11) to 1 x10(-4) M) or ergotamine (1 x10(-11) to 1 x 10(-5) M) were administered every 15 min after buffer replacement. Contractile response data were normalized to a percentage induced by a reference dose of norepinephrine (1 x10(-4) M). Contractile responses of saphenous veins were similar for ergovaline and ergotamine. Initial contractile responses began at 1 x10(-8) M for both ergovaline and ergotamine (4.4 +/- 0.8% and 5.6 +/-1.1%, respectively). Vascular tension continued to increase as the alkaloid concentrations increased (maximums: 43.7 +/-7.1% at 1 x10(-5) M ergotamine; 69.6 +/- 5.3% at 1 x10(-4) M ergovaline). Interestingly, ergovaline-induced contractions (1 x10(-4) M) were not reversed by repeated buffer replacement over a 105-min period. As previously shown with ergotamine, these results confirm that ergovaline is a potent vasoconstrictor. The resistance of an ergovaline-induced contraction to relaxation over an extended period of time suggests a potential for bioaccumulation of this ergopeptine alkaloid and may aid in understanding its toxicity within the animal.

摘要

麦角瓦灵被认为是内生真菌感染的高羊茅中的一种有毒成分。由于许多高羊茅中毒症状是循环系统受损的结果,本研究的目的是使用牛的外侧(颅支)隐静脉生物测定法,检测麦角瓦灵和一种记录更详尽的麦角肽碱——麦角胺的血管收缩潜力。从当地屠宰场的健康杂交牛(麦角瓦灵和麦角胺实验分别为n = 12头和n = 5头)采集外侧隐静脉颅支段(2至3厘米)。去除静脉多余的脂肪和结缔组织,切成2至3毫米的横截面,悬挂于含有5毫升改良克雷布斯 - 亨泽莱特充氧缓冲液(95% O₂ + 5% CO₂;pH = 7.4;37℃)的肌张力测定仪腔室中。在添加处理剂之前,使组织在1克张力下平衡90分钟。更换缓冲液后,每隔15分钟给予递增剂量的麦角瓦灵(1×10⁻¹¹至1×10⁻⁴ M)或麦角胺(1×10⁻¹¹至1×10⁻⁵ M)。收缩反应数据以去甲肾上腺素参考剂量(1×10⁻⁴ M)诱导的百分比进行标准化。麦角瓦灵和麦角胺对隐静脉的收缩反应相似。麦角瓦灵和麦角胺的初始收缩反应均始于1×10⁻⁸ M(分别为4.4±0.8%和5.6±1.1%)。随着生物碱浓度增加,血管张力持续升高(最大值:麦角胺1×10⁻⁵ M时为43.7±7.1%;麦角瓦灵1×10⁻⁴ M时为69.6±5.3%)。有趣的是,在105分钟内反复更换缓冲液并不能逆转麦角瓦灵(1×10⁻⁴ M)诱导的收缩。如先前麦角胺所示,这些结果证实麦角瓦灵是一种强效血管收缩剂。麦角瓦灵诱导的收缩在较长时间内对松弛具有抗性,这表明这种麦角肽碱生物碱可能存在生物累积的可能性,并可能有助于理解其在动物体内的毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验